Nestlé has launched a plant-based drink for toddlers named Little Steps Plantygrow, which can be added to smoothies and shakes.
The company emphasized that the plant-based 'Growing Up Drink,' marketed under its SMA Nutrition range, is not a breast milk substitute, but a nutritional product designed to be enjoyed by toddlers from 1 to 3 years old as part of a varied and balanced diet.
According to Nestlé, Little Steps is a good source of vitamins A, C, B2, and B12, iron, iodine and omega-3, and omega-6. The drink also contains calcium and vitamin D.
Vicky Woods, SMA Nutrition managing director, noted that consumers are increasingly choosing plant-based milk alternatives for themselves and as nutrient-packed options for their toddlers.
The new product is a ready-to-drink liquid that is packaged in resealable cartons for portability. Tesco and Asda carry a 200 ml pack. A 1-liter pack will be available at Asda.


Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Vanda Pharmaceuticals (VNDA) Stock Soars After FDA Approves BYSANTI for Bipolar I and Schizophrenia
Gold Prices Drop Amid Iran Peace Talk Uncertainty and Stronger Dollar
U.S. Praises Kurdistan's Role in Oil Markets Amid Iran War Fallout
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Meta Ties Executive Pay to Aggressive Stock Price Targets in Major Retention Push
Time to buy local: war fuel price shocks reveal the folly of a long food supply chain
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Japan Eyes Oil Futures Intervention to Stabilize Yen Amid Middle East Crisis
Oil Prices Climb as Iran Reviews U.S. Peace Proposal Amid Middle East Tensions
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 



